Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5930-5938

  Scotton, Chris J ^a   Wilson, Julia L ^a   Scott, Kate ^a   Stamp, Gordon ^b   Wilbanks, George D ^a,c   Fricker, Simon ^d   Bridger, Gary ^d   Balkwill, Frances R ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIVISION; CHEMOKINES, CXC; ENZYME ACTIVATION; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037108923     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rossi, D., and Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242, 2000
2. Balkwill. F., and Mantovani, A. Inflammation and cancer: Back to Virchow. Lancet, 357: 539-545, 2001
3. Vicari, A. P., and Caux, C. Chemokines in cancer. Cytokine Growth Factor Rev., 13: 143-145, 2002
4. Scotton, C., Milliken, D., Wilson, J., Raju, S., and Balkwill, F. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br. J. Cancer, 85: 891-897, 2001
5. Negus, R. P. M., Stamp, G. W. H., Hadley, J., and Balkwill. F. R. A quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol., 150: 1723-1734, 1997
6. Negus, R. P. M., Stamp, G. W. H., Relf, M. G., Burke, F., Malik, S. T. A., Bernasconi, S., Allavena. P., Sozzani, S., Mantovani, A., and Balkwill, F. R. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Investig., 95: 2391-2396, 1995
7. Milliken, D., Scotton, C., Raju, S., Balkwill, F., and Wilson, J. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin. Cancer Res., 8: 1108-1114, 2002
8. Strieter, R. M. Chemokines: Not just leukocyte chemoattractants in the promotion of cancer. Nat. Immunol., 2: 285-286, 2001
9. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M. CXC chemokines in angiogenesis. J. Leukocyte Biol., 68: 1-8, 2000
10. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., and Balkwill, F. R. Epithelial cancer cell migration: A role for chemokine receptors? Cancer Res., 61: 4961-4965, 2001
11. Muller. A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegul. E., and Zlotnik. A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.), 410: 50-56, 2001
12. Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I: P., and Ben-Baruch, A. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases and neuroblastoma. J. Immunol., 167: 4747-4757, 2001
13. Jones, D., Benjamin, R. J., Shahsafaei, A., and Dorfman, D. M. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood., 95: 627-632, 2000
14. Mohle, R., Schittenhelm, M., Failenschmid, C., Bautz, F., Kratz-Albers, K., Serve, H., Brugger, W., and Kanz. L. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br. J. Haematol., 110: 563-572, 2000
15. Rempel, S. A., Dudas, S., Ge, S., and Gutierrez, J. A. Identification and localization of the cytokine SDF1 and its receptor. CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res., 6: 102-111, 2000
16. Murphy, P. M. Chemokines and the molecular basis of cancer metastasis. N. Eng. J. Med., 345: 833-835, 2001
17. Taichman, R. S., Cooper, C., Keller, E. T., Pienta, K. J., Taichman, N. S., and McCauley, L. K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res., 62: 1832-1837, 2002
18. Wiley, H. E., Gonzalez, E. B., Maki, S., Wu, M-T., and Hwang, S. T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B 16 murine melanoma. J. Cell. Biochem. Suppl., 93: 1638-1643, 2001
19. Zou, W., Machelon, V., Coulomb-l'Hermin, A., Borvak, J., Nome,. F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., Pustilnik, T., Curiel, D. T., Galanaud, P., Capron, F., Emilie, D., and Curiel, T. J. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med., 7: 1339-1346, 2001
20. Benard, J., Da Silva, J., De Blois, M. C., Boyer, P., Duvillard. P., Chiric, E., and Riou, G., Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res., 45: 4970-4979, 1985
21. Schols, D., Struyf. S., Van Damme, J., Este, J. E., Henson, G., and De Clercq, E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med., 186: 1383-1388. 1997
22. Chan, T. O., Rittenhouse, S. E., and Tsichlis, P. N. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem., 68: 965-1014, 1999
23. Meili. R., Ellsworth, C., Lee, S., Reddy, T. B. K., Ma, H., and Firtel, R. A. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J., 18: 2092-2105, 1999
24. Majka, M., Ratajczak, J., Kowalska, M. A., and Ratajczak. M. Z. Binding of stromal derived factor-1α (SDF-1α) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-I transcription factor and serine'threonine kinase AKT. Eur. J. Haematol., 64: 164-172, 2000
25. Han, Y., He, T., Huang, D., Pardo, C. A., and Ransohoff, R. M. TNF-a mediates SDF-la-induced NF-kB activation and cytotoxic effects in primary astrocytes. J. Clin. Investig., 108: 425-435, 2001
26. Naylor, M. S., Stamp, G. W. H., Foulkes. W. D., Eccles, D., and Balkwill, F. R. Tumor necrosis factor and its receptors in human ovarian cancer. J. Clin. Investig., 91: 2194-2206,. 1993
27. Robinson, S. C., Scott, K. A., and Balkwill, F. R., Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-a. Eur. J. Immunol., 32: 404-412, 2002
28. Servant, G., Weiner, O. D., Herzmark, P., Balla. T., Sedat, J. W., and Bourne, H. R. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science (Wash. DC), 287: 1037-1040, 2000
29. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay. N., The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11: 701-713, 1997
30. Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi. T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., and Testa, J. R. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA, 89: 9267-9271, 1992
31. Graff, J. R., Konicek, B. W., McNulty, A. M., Wang, Z., Houck, K., Allen. S., Paul, J. D., Hbaiu, A., Goode, R. G., Sandusky, G. E., Vessella, R. L., and Neubauer, B. L. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kipl expression. J. Biol. Chem., 275: 24500-24505, 2000
32. Nelson, A. R., Fingleton, B., Rothenberg, M. L., and Matrisian, L. M. Matrix metalloproteinases: Biologic activity and clinical implications. J. Clin. Oncol., 18. 1135-1149, 2000
33. Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K, Processing of tumour necrosis factor-a precursor by metalloproteinases. Nature (Lond.), 370: 555-561, 1994
34. Kawashima, A., Kawahara, E., Tokuda, R., and Nakanishi, I., Tumour necrosis factor-α provokes up-regulation of α2β1 and α5β1 integrins, and cell migration in OST osteosarcoma cells. Cell Biol. Int., 25: 319-329, 2001
35. Laferriere, J., Houle, F., Taher, M. M., Valerie, K., and Huot, J. Transdenothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J. Biol. Chem., 276: 33762-33772, 2001
36. Harimaya, K., Tanaka, K., Matsumoto, Y., Sato, H., Matsuda, S., and Iwamoto. Y. Antioxidants inhibit TNFα-induced motility and invasion of human osteosarcoma cells: Possible involvement of NF-κB activation. Clin. Exp. Metastasis, 18: 121-129, 2000
37. Balkwill, F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev., 13: 135-141, 2002
38. Donzella. G. A., Schols, D., Lin, S, W., Este, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G, P., Sakmar,. T. P., Henson, G., De Clereq, E., and Moore, J. P. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med., 4: 72-77, 1998
39. Hendrix, C. W., Flexner. C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridget, G., and Henson, G. W. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother., 44: 1667-1673, 2000
40. Liles, W. C., Broxmeyer, H. E., Rodger,. E., Hubel, K., Cooper, G., Hangoc, G., Bridget, G. J., Henson, G. W., Calandra, G., and Dale. D. G., Leukocytosis and mobilization of pluripotent hematopoietic progenitor cells in healthy volunteers induced by single dose administration of AMD-3100, a CXCR-4 antagonist. Blood, 98: 737a, 2001
41. Datema, R., Rabin, L., Hincenbergs, M., Morena, M. B., Warren, S., Linquist, V., Rosenwirth, B., Seifert, I., and McCune, J. M. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 341), an inhibitor of infectious cell entry. Antimicrob. Agents Chemother., 40: 750-754, 1996
42. Matthys, P., Hatse, S., Vermeire, K., Wuyts, A., Bridger, G., Henson, G. W., De Clereq, E., Billiau, A., and Schols, D. AMD31000, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-γ receptor-deficient mice. J. Immunol., 167: 4686-4692, 2001